Masayuki Sakurai

Optimal Treatment Strategy for Patients With Paroxysmal Atrial Fibrillation J-RHYTHM Study

Satoshi Ogawa, Takeshi Yamashita, Tsutomu Yamazaki et al. · Circulation Journal · 2009 · 208 citations · Full text

Medicine, Cardiology, Cardiovascular Pharmacotherapy +12

Drug-Induced Long-QT Syndrome Associated With a Subclinical <i>SCN5A</i> Mutation

Naomasa Makita, Minoru Horie, Takeshi Nakamura et al. · Circulation · 2002 · 178 citations · Full text

Medicine, Cardiology, Pharmacology +17

Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain

Yuko Kawai, Eriko Tsukamoto, Yoichi Nozaki et al. · Journal of the American College of Cardiology · 2001 · 136 citations

Medicine, Internal Medicine, Nuclear Medicine +4

Target International Normalized Ratio Values for Preventing Thromboembolic and Hemorrhagic Events in Japanese Patients With Non-Valvular Atrial Fibrillation

Hiroshi Inoue, Ken Okumura, Hirotsugu Atarashi et al. · Circulation Journal · 2013 · 122 citations · Full text

Medicine, Cardiology, Hematology +17

A Randomized Comparison of Pioglitazone to Inhibit Restenosis After Coronary Stenting in Patients With Type 2 Diabetes

Kazuaki Nishio, Masayuki Sakurai, Taro Kusuyama et al. · Diabetes Care · 2006 · 96 citations · Full text

Medicine, Cardiology, Pharmacology +17